Immatics (IMTX) EBITDA Margin Growth (1y) (2020 - 2026)
Powered by 
Analysis
Immatics (IMTX) EBITDA Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - | 38,658.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38,658.00 |
| Mar 31, 2026 | -67,753.00 |
| Dec 31, 2025 | -19,836.00 |
| Sep 30, 2025 | -105,428.00 |
| Jun 30, 2025 | -97,990.00 |
| Mar 31, 2025 | -14,587.00 |
| Dec 31, 2024 | 17,568.00 |
| Sep 30, 2024 | 56,239.00 |
| Jun 30, 2024 | -7,760.00 |
| Mar 31, 2024 | 22,531.00 |
| Dec 31, 2023 | -17,419.00 |
| Sep 30, 2023 | -41,579.00 |
| Jun 30, 2023 | 3,272.00 |
| Mar 31, 2023 | -33,636.00 |
| Dec 31, 2022 | 10,224.00 |
| Sep 30, 2022 | 21,141.00 |
| Jun 30, 2022 | 35,412.00 |
| Mar 31, 2022 | 38,856.00 |
| Dec 31, 2021 | 10,993.00 |
| Sep 30, 2021 | -11,818.00 |